The Nuclear Transport Protein Importin-5: A Promising Target in Oncology and Virology.


Journal

Chimia
ISSN: 0009-4293
Titre abrégé: Chimia (Aarau)
Pays: Switzerland
ID NLM: 0373152

Informations de publication

Date de publication:
28 Apr 2021
Historique:
entrez: 27 4 2021
pubmed: 28 4 2021
medline: 29 4 2021
Statut: ppublish

Résumé

Cellular homeostasis importantly relies on the correct nucleoplasmic distribution of a large number of RNA molecules and proteins, which are shuttled by specialized transport receptors. The nuclear import receptor importin-5, also called IPO5, RanBP5 or karyopherin β3, mediates the translocation of proteins to the nucleus, and thus regulates critical signaling pathways and cellular functions. The normal function of IPO5 appears to be disrupted in cancer cells due to aberrant overexpression. IPO5 also demonstrated a pivotal role in viral replication. The constant increasing number of publications shows an interest within the scientific community as a therapeutic target due to its pivotal role in protein trafficking.

Identifiants

pubmed: 33902802
doi: 10.2533/chimia.2021.319
doi:

Substances chimiques

Karyopherins 0
Nuclear Proteins 0
beta Karyopherins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

319-322

Auteurs

Rémi Patouret (R)

Faculty of Science, Department of Organic Chemistry, 30 quai Ernest Ansermet, CH-1211 Geneva 4;, Email: remi.patouret@unige.ch.

Articles similaires

Testicular Neoplasms Neoplasms, Germ Cell and Embryonal Humans Cisplatin Jumonji Domain-Containing Histone Demethylases
Animals Active Transport, Cell Nucleus RNA, Messenger Humans SARS-CoV-2
Sarcoma, Ewing Humans Cell Line, Tumor Epithelial-Mesenchymal Transition Mutation
Humans Ku Autoantigen Ataxia Telangiectasia Mutated Proteins Male DNA-Activated Protein Kinase

Classifications MeSH